Search · resolved
Which podcasts are discussing MRNA?
6 ATTRIBUTED IDEAS · 5 EPISODES · 3 SHOWS
The shows
CNBC Fast Money
WSJ What's News
Motley Fool Money
Where the discussion went deepest
19 AUGYESTERDAYCNBC FAST MONEY · 13:00
Moderna's cancer vaccine validates mRNA platform
“The bull case argued that Moderna's positive late-stage cancer vaccine trial proves mRNA technology is viable beyond respiratory diseases, driving a massive short squeeze.”
Treasury intervention sparks rate relief... And Moderna’s cancer moonshot 8/19/26
In depth · 4/5Verify in source →
19 AUGYESTERDAYWSJ WHAT'S NEWS · 01:30
Moderna cancer vaccine trial success
“The bull case for Moderna and Merck was framed around a successful late-stage trial of a personalized mRNA cancer vaccine for melanoma, validating decades of research and paving the way for a potential new treatment.”
A New Milestone for U.S. Debt: $40 Trillion
In depth · 4/5Verify in source →
19 AUGYESTERDAYMOTLEY FOOL MONEY · 15:00
Moderna cancer vaccine a major proof of concept
“The case made was that Moderna's positive Phase 3 trial results for its personalized mRNA cancer vaccine represent a transformative proof of concept that could diversify its revenue and significantly expand its addressable market into oncology.”
Behind The Most Exciting Stock Pop In Years!
In depth · 4/5Verify in source →
26 JUN26 JUNCNBC FAST MONEY
Rotate from tech into underperforming healthcare
“Traders noted a market rotation out of expensive mega-cap tech into defensive, underperforming healthcare and small-cap biotech names.”
Is the Tech Slump Here to Stay?… And Opportunities Outside of Software 6/26/26
In depth · 4/5Verify in source →
26 JUN26 JUNCNBC FAST MONEY
Biotech momentum accelerates on heavy M&A and trial data
“The biotech sector is undergoing a sustained structural rally driven by strategic pharma investments, M&A activity, and upcoming clinical catalysts.”
Is the Tech Slump Here to Stay?… And Opportunities Outside of Software 6/26/26
Substantive discussion · 3/5Verify in source →
6 AUG2W AGOWSJ WHAT'S NEWS · 07:20
Moderna's mRNA flu vaccine approved
“The report noted the FDA approved Moderna's mRNA flu vaccine, which showed efficacy in trials, but Wall Street expectations for meaningful sales are several years out.”
Why Trump Keeps Calling Kevin Warsh
Notable comment · 2/5Verify in source →
The weekly signal
Get a weekly digest of what podcasts said about your watchlist.
Pick a few tickers. Once a week we send the most-discussed ideas across finance podcasts, attributed and linked so you can verify. No noise, no advice.
Double opt-in: we’ll email you to confirm before anything else. We store your email and chosen tickers only to send this digest. Nothing else, and we never share them.